lactic acid has been researched along with amphotericin b, deoxycholate drug combination in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amaral, AC; Bentes, R; Bocca, AL; Felipe, MS; Lacava, ZG; Morais, PC; Nunes, J; Peixoto, DL; Primo, FL; Ribeiro, AM; Simioni, AR; Tedesco, AC; Titze-de-Almeida, R | 1 |
Amaral, AC; Báo, SN; Bocca, AL; Borin, MF; Cardoso, VN; Cintra, DO; de Vasconcelos, NM; Felipe, MS; Fernandes, SO; Fuscaldi, LL; Jerônimo, MS; Martins, OP; Mortari, MR; Nascimento, AL; Pires Júnior, OR; R-Santos, L; Siqueira, IM; Souza, AC; Tedesco, AC; Titze-de-Almeida, R | 1 |
2 other study(ies) available for lactic acid and amphotericin b, deoxycholate drug combination
Article | Year |
---|---|
Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis.
Topics: Amphotericin B; Animals; Body Weight; Bone Marrow; Colony Count, Microbial; Deoxycholic Acid; Drug Combinations; Female; Kidney; Lactic Acid; Liver; Lung; Mice; Mice, Inbred BALB C; Nanoparticles; Paracoccidioides; Paracoccidioidomycosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Succimer; Treatment Outcome | 2009 |
Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles.
Topics: Amphotericin B; Animals; Antifungal Agents; Deoxycholic Acid; Drug Carriers; Drug Combinations; Drug Liberation; Lactic Acid; Materials Testing; Mice; Nanoparticles; Paracoccidioides; Paracoccidioidomycosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Safety; Succimer; Tissue Distribution | 2015 |